Debasish Saha

Summary

Affiliation: International Centre for Diarrhoeal Disease Research
Country: Bangladesh

Publications

  1. ncbi request reprint Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial
    Debasish Saha
    ICDDR, B, Centre for Health and Population Research, Dhaka, Bangladesh
    Lancet 366:1085-93. 2005
  2. ncbi request reprint Single-dose azithromycin for the treatment of cholera in adults
    Debasish Saha
    International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh
    N Engl J Med 354:2452-62. 2006
  3. ncbi request reprint Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial
    Wasif A Khan
    Clinical Sciences Division, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka
    Lancet 360:1722-7. 2002
  4. pmc Efficacy of a high-dose in addition to daily low-dose vitamin A in children suffering from severe acute malnutrition with other illnesses
    Samima Sattar
    Clinical Sciences Division and Centre for Nutrition and Food Security, International Centre for Diarrhoeal Disease Research, Bangladesh ICDDR, B, Dhaka, Bangladesh
    PLoS ONE 7:e33112. 2012
  5. ncbi request reprint Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh
    Debasish Saha
    International Centre for Diarrheal Disease Research, Bangladesh
    J Infect Dis 189:2318-22. 2004
  6. ncbi request reprint Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh
    Michael L Bennish
    Africa Centre for Health and Population Studies, Mtubatuba, South Africa
    Clin Infect Dis 42:356-62. 2006
  7. pmc Emergence of multidrug-resistant strain of Vibrio cholerae O1 in Bangladesh and reversal of their susceptibility to tetracycline after two years
    Abu S G Faruque
    J Health Popul Nutr 25:241-3. 2007

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial
    Debasish Saha
    ICDDR, B, Centre for Health and Population Research, Dhaka, Bangladesh
    Lancet 366:1085-93. 2005
    ..We assessed whether single-dose ciprofloxacin would be as effective as 3-day, 12-dose erythromycin in achieving clinical cure in children with severe cholera...
  2. ncbi request reprint Single-dose azithromycin for the treatment of cholera in adults
    Debasish Saha
    International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh
    N Engl J Med 354:2452-62. 2006
    ..Single-dose azithromycin is effective in the treatment of severe cholera in children, but its effectiveness in adults has not been evaluated...
  3. ncbi request reprint Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial
    Wasif A Khan
    Clinical Sciences Division, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka
    Lancet 360:1722-7. 2002
    ..However, effective single-dose antimicrobial regimens have been identified only for adults. Our aim was to compare the efficacy of azithromycin and erythromycin regimens in the treatment of children...
  4. pmc Efficacy of a high-dose in addition to daily low-dose vitamin A in children suffering from severe acute malnutrition with other illnesses
    Samima Sattar
    Clinical Sciences Division and Centre for Nutrition and Food Security, International Centre for Diarrhoeal Disease Research, Bangladesh ICDDR, B, Dhaka, Bangladesh
    PLoS ONE 7:e33112. 2012
    ..This study compared the efficacy of a single high-dose (200,000 IU) in addition to daily low-dose (5000 IU) VA in the management of children suffering from SAM with diarrhea and/or acute lower respiratory tract infection (ALRI)...
  5. ncbi request reprint Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh
    Debasish Saha
    International Centre for Diarrheal Disease Research, Bangladesh
    J Infect Dis 189:2318-22. 2004
    ..No association between baseline vibriocidal titer and protection from V. cholerae O139 infection was found. Our findings suggest that the vibriocidal antibody is an incomplete predictor of protection from V. cholerae infection...
  6. ncbi request reprint Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh
    Michael L Bennish
    Africa Centre for Health and Population Studies, Mtubatuba, South Africa
    Clin Infect Dis 42:356-62. 2006
    ..Shigella dysenteriae type 1 also expresses Stx. However, the effect of antimicrobial therapy on Stx release and the risk of HUS in humans is unknown...
  7. pmc Emergence of multidrug-resistant strain of Vibrio cholerae O1 in Bangladesh and reversal of their susceptibility to tetracycline after two years
    Abu S G Faruque
    J Health Popul Nutr 25:241-3. 2007